SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024055
Filing Date
2021-05-05
Accepted
2021-05-05 16:11:29
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tptx-10q_20210331.htm   iXBRL 10-Q 2190581
2 EX-10.3 tptx-ex103_12.htm EX-10.3 15896
3 EX-31.1 tptx-ex311_6.htm EX-31.1 21727
4 EX-31.2 tptx-ex312_7.htm EX-31.2 21825
5 EX-32.1 tptx-ex321_8.htm EX-32.1 10183
6 EX-32.2 tptx-ex322_9.htm EX-32.2 10214
  Complete submission text file 0001564590-21-024055.txt   7359099

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tptx-20210331.xsd EX-101.SCH 38798
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tptx-20210331_cal.xml EX-101.CAL 38248
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tptx-20210331_def.xml EX-101.DEF 138171
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tptx-20210331_lab.xml EX-101.LAB 335408
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tptx-20210331_pre.xml EX-101.PRE 269427
12 EXTRACTED XBRL INSTANCE DOCUMENT tptx-10q_20210331_htm.xml XML 1412226
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38871 | Film No.: 21893356
SIC: 2834 Pharmaceutical Preparations